Aldeyra Therapeutics Completes $7.79 Million Private Placement
January 15, 2015Aldeyra Therapeutics closes its previously announced $7.79 million private placement of common stock and warrants. Pursuant to the teams of the private placement, they sold an aggregate of approximately 1.1 million shares of common stock at $7.00 per shar
More »
Obalon Therapeutics Secures $30 Million to Advance Weight-Loss Device to Pivotal Trial in U.S.
January 14, 2015Obalon Therapeutics completes a $20 million Series D private equity financing and a $10 million term loan from Square 1 Bank. A new syndicate of international investors participated, as well as existing investors Domain Associates, InterWest Partners and
More »
Regado Biosciences and Tobira Therapeutics Announce Merger Agreement to Create Leading NASH Company
January 14, 2015Regado Biosciences enters definitive agreement with Tobira Therapeutics, which upon closing will take on Tobira’s name. The total cash balance of the merger is expected to be $60M and will provide financing for Tobira’s Phase 2b NASH program.
More »